Tampa, FLNCT04925375Now EnrollingIRB Ready

Common Variable Immunodeficiency Clinical Trial in Tampa, FL

Access cutting-edge common variable immunodeficiency treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.

Sponsored by Children's Hospital Medical Center, Cincinnati

Quick Self-Assessment

See if you qualify for this Tampa location

Preparing your pre-screening questions...

Expert Care in Tampa

Access common variable immunodeficiency specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related common variable immunodeficiency treatment provided free

Apply for This Tampa Location

Check if you qualify for this common variable immunodeficiency clinical trial in Tampa, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tampa

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tampa site if eligible
  4. 4Begin participation

About This Common Variable Immunodeficiency Study in Tampa

There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has recently looked promising for the treatment of patients with complex CVID. This study is a multi-site, phase II, randomized, blinded/placebo-controlled clinical trial in pediatric and adult subjects to determine the efficacy of abatacept compared to placebo for treatment of subjects with GLILD in the context of CVID. Fu

Sponsor: Children's Hospital Medical Center, Cincinnati

Who Can Participate

Inclusion Criteria

Diagnosis of CVID according to the international consensus document (ICON) 1. Age 4 years or above 2. Serum IgG at least 2 standard deviations below the age adjusted normal 3. Decreased serum IgA and/or serum IgM 4. Abnormal specific antibody response to immunization 5.

Exclusion Criteria

of secondary immunodeficiency 2. On replacement immunoglobulin for at least 6 months and willing to maintain throughout study 3. Granulomatous-lymphocytic interstitial lung disease with a lymphocytic component diagnosed by lung biopsy prior to study entry, wedge biopsy preferred. 4. Persistence or worsening of interstitial lung disease measured on serial CT imaging of the lung at least 6 months apart, with the latest assessment within 3 months of study entry. 5. Signed written informed consent 6. Willing to allow storage of biological specimens for future use in medical research. 7. Female subjects of childbearing potential must agree to an effective form of birth contro

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tampa?

Yes, this clinical trial (NCT04925375) has an active research site in Tampa, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Common Variable Immunodeficiency Treatment Options in Tampa, FL

If you're searching for common variable immunodeficiency treatment options in Tampa, FL, this clinical trial (NCT04925375) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced common variable immunodeficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all common variable immunodeficiency clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Tampa, FL

See all multiple myeloma clinical trials recruiting in Tampa — not just this study.

Browse Multiple Myeloma Trials in Tampa →

Browse More Trials by Condition

Multiple Myeloma TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Tampa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tampa, FL